BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 28195089)

  • 21. Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study.
    Chaoui D; Choquet S; Sanhes L; Mahé B; Hacini M; Fitoussi O; Arkam Y; Orfeuvre H; Dilhuydy MS; Barry M; Jourdan E; Dreyfus B; Tempescul A; Leprêtre S; Bardet A; Leconte P; Maynadié M; Delmer A
    Leuk Lymphoma; 2017 Jun; 58(6):1366-1375. PubMed ID: 28271952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.
    García-Álvarez M; Alcoceba M; López-Parra M; Puig N; Antón A; Balanzategui A; Prieto-Conde I; Jiménez C; Sarasquete ME; Chillón MC; Gutiérrez ML; Corral R; Alonso JM; Queizán JA; Vidán J; Pardal E; Peñarrubia MJ; Bastida JM; García-Sanz R; Marín L; González M
    PLoS One; 2017; 12(3):e0172978. PubMed ID: 28249016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high-risk features and reduced treatment-free-intervals.
    Elizabeth S; Aidan K; David OB; Deirdre W; Sarah B; Emer A; Kanthi P; Crotty GM; Aileen W; Michelle C; Ruth C; Hilary O; Ashique K; Bacon CL; Emily S; McElligott AM; Fiona Q; Elisabeth V; Carmel W
    Eur J Haematol; 2022 Nov; 109(5):441-446. PubMed ID: 35776688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression.
    Srinivasan VK; Naseem S; Varma N; Lad DP; Malhotra P
    Blood Res; 2020 Sep; 55(3):131-138. PubMed ID: 32747613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic markers in Chronic Lymphocytic Leukaemia - A flow cytometric analysis.
    Haq H; Uddin N; Khan SA; Ghaffar S
    Pak J Med Sci; 2020; 36(3):338-343. PubMed ID: 32292430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin gene analysis as a tool for investigating human immune responses.
    Dunn-Walters D; Townsend C; Sinclair E; Stewart A
    Immunol Rev; 2018 Jul; 284(1):132-147. PubMed ID: 29944755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
    Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
    Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Overrepresentation of specific gene segments of expressed immunoglobulin heavy chain variable region among unmutated and mutated patients with chronic lymphocytic leukemia].
    Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Qi JY; Li CH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):529-32. PubMed ID: 22338175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clonality analysis and mutation status of IgVH genes in classic Richter's syndrome].
    Mao ZR; Rosenwald A; Zhang SJ; Zhou R; Mueller-Hermelink HK
    Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):364-70. PubMed ID: 19031714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.
    Chen L; Zhang Y; Zheng W; Wu Y; Qiao C; Fan L; Xu W; Li J
    Leuk Res; 2008 Oct; 32(10):1491-8. PubMed ID: 18359082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
    Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenetics of chronic lymphocytic leukemia.
    Patkar N; Rabade N; Kadam PA; Mishra F; Muranjan A; Tembhare P; Chaudhary S; Joshi S; Jain H; Dangi U; Bagal B; Khattry N; Menon H; Gujral S; Sengar M; Subramanian PG
    Indian J Pathol Microbiol; 2017; 60(1):38-42. PubMed ID: 28195089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
    Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
    Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.